Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
NCT ID: NCT02650141
Last Updated: 2019-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
143 participants
INTERVENTIONAL
2013-04-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty
NCT07325903
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
NCT06510764
Indicators and Evaluation of Efficacy of Yin-nourishing and Fire-reducing Chinese Medicine for Girls With Rapid Progression of Early Puberty
NCT06820931
Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls' Sexual Precocity
NCT04665713
Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of Phlegm-Dampness Internal Accumulation Type
NCT07141615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ziyinxiehuo Granules
Children of ziyinxiehuo granules group will be treated with chinese herbal granules,3 times a day, for 6 months.
ziyinxiehuo Granules
Ziyinxiehuo granules Herbs (1 bag ): shengdi 5g, xuanshen 3g, zexie 3g, zhimu3g, huangpai 3g, zhiguiban 2g, maiya 6g,tiandong 3g, zhigancao 2g Therapeutic Principle: Nourishing "Yin", removing "Fire" Usage: administered after dissolved, 3 times per day after breakfast and supper
zishenqinggan Granules
Children of zishenqinggan granules group will be treated with chinese herbal granules, 3 times a day, for 6 months.
zishenqinggan Granules
Zishenqinggan granules Herbs (1 bag ): Shengdi 5g, baishao 3g, huangqin 3g, fuling 4g, danpi 3g, maiya 6g, shanzha 3g, zhebei 3g, zhigancao 2g Therapeutic Principle: replenishing "Kidney", Clearing "Liver" Usage: administered after dissolved, 3 times per day after breakfast and supper
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ziyinxiehuo Granules
Ziyinxiehuo granules Herbs (1 bag ): shengdi 5g, xuanshen 3g, zexie 3g, zhimu3g, huangpai 3g, zhiguiban 2g, maiya 6g,tiandong 3g, zhigancao 2g Therapeutic Principle: Nourishing "Yin", removing "Fire" Usage: administered after dissolved, 3 times per day after breakfast and supper
zishenqinggan Granules
Zishenqinggan granules Herbs (1 bag ): Shengdi 5g, baishao 3g, huangqin 3g, fuling 4g, danpi 3g, maiya 6g, shanzha 3g, zhebei 3g, zhigancao 2g Therapeutic Principle: replenishing "Kidney", Clearing "Liver" Usage: administered after dissolved, 3 times per day after breakfast and supper
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tanner stages of breast in female patients are Tanner II and Tanner III, Diameter of mammary nucleus is less than 3cm;
* B-type ultrasonography: the size and volume of uterus and follicle is in the normal range at the same age;
* bone age: the bone age in the patients are the same with their actual age.
* Girls are diagnosed as Idiopathic central precocious puberty,and their age of onset ≤8 years
* Tanner stages of brest in female patients ≤ Tanner III stage,diameter of mammillary nucleus \< 3cm
* B-type ultrasonography: the volume of uterus≥1\~3ml,the diameter of follicle≥4mm;or the length of uterus ≥3.4-4cm
* bone age: compared the actual age ,the bone age is no more than 1 year and the bone age \<10 years old;
* in master single test: LH \>3 IU/L
* GnRH stimulation test: LH/FSH\>0.6, the Peak LH 3.5\~5.0 IU/L, the Peak LH 3.5\~5.0 IU/L.
Exclusion Criteria
* pseudo sexual precocity, including gonadal tumor,adrenal disease,exogenous intake induced with hormone drugs or food and multiple bone fiber structure dysplasia of precocious puberty (McCune Albright syndrome)
* heterosexual precocious puberty
2. In the mild true precocious puberty children:
* The central nervous system organic diseases caused sexual precocity
* congenital thyroid function reduce disease with precocious puberty, congenital adrenal hyperplasia, adrenal tumor
* ovarian or testicular neoplasms,
* McCune Albright syndrome (precocious puberty with polyostotic fibrous dysplasia and skin pigment abnormalities, pigmentation)
* there is a family history of diseases such as tumor, leukemia, diabetes, systemic lupus erythematosus, etc
* precocious puberty and partial precocious puberty
8 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jian Yu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian Y Jian, professor
Role: STUDY_CHAIR
Children Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Chinses Traditional Medcine; Children Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sun W, Han X, Wang Y, Yu J, Yan W, Zhao J, Chen W, Xue Z. Effectiveness of ZiYin Xiehuo granules and Zishen Qinggan granules on partial precocious puberty in girls: a multicenter, randomized, single-blind, controlled trial. J Tradit Chin Med. 2018 Oct;38(5):740-745.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NO.12401905505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.